# A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy

> **NCT00414908** · PHASE3 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 52 (actual)

## Conditions studied

- Chronic Pancreatitis
- Pancreatectomy
- Pancreatic Exocrine Insufficiency

## Interventions

- **DRUG:** Pancrelipase delayed release capsule
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT00414908
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-08
- **Final completion:** 2009-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2011-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00414908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00414908, "A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00414908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*